bioRxivNeurosciencePreprint
Human induced pluripotent stem cell-derived microglia with a CX3CR1-V249I genetic variant exhibit dysfunctional phenotypes and modulate neuronal growth and function
Kaylee D. Tutrow, Jade HarkiniD, L. VargheseiD, Melody HernandeziD, Kang-Chieh HuangiD, Yue Fang, Parker Wilcox, Logan M. BedfordiD, Tsai‐Yu LiniD, Chi ZhangiD, Cátia GomesiD, Shweta S. Puntambekar, Stephanie J. BisseliD, Bruce T. LambiD, Jason S. MeyeriD
Abstract
The involvement of microglia in neurodegenerative diseases has drawn increasing attention, as many genetic risk factors are preferentially expressed in microglia. Microglial fractalkine receptor (CX3CR1) signaling regulates many key microglial functions, and the CX3CR1-V249I single nucleotide polymorphism (SNP) has been associated with increased risk for multiple neurodegenerative conditions, including Alzheimers disease, yet its functional consequences in human microglia remain unexplored. In this study, we generated iPSC-derived human microglia-like cells (hMGLs) and found that the CX3CR1-V249I variant increased susceptibility to starvation-induced cell death, reduced amyloid-beta uptake, altered microglial morphology, and impaired migration, with more pronounced effects in homozygous cells. Co-culture with neurons demonstrated that hMGLs with the CX3CR1-V249I variant misregulated neuronal properties, including abnormal neuronal growth as well as an induction of neuronal hyperexcitability. These findings highlight the critical role of CX3CR1 in regulating microglial function and implicate the V249I variant in driving pathogenic microglial states relevant to neurodegeneration.
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell-cell communication
- approach: experimental assay
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Microglial CX3CR1I249/M280 variant limits neurogenesis and remyelination in cuprizone-induced multiple sclerosis model
Andrew S. Mendiola, Kaira A. Church, … Astrid E. Cardona·bioRxiv·Jun 6, 2021
- An adapted stem cell-derived microglia protocol for the study of microgliopathies and other neurological disorders
Marie‐France Dorion, Diana Casas, … Luke M. Healy·bioRxiv·Sep 8, 2023
- Transcriptional characterization of iPSC-derived microglia as a model for therapeutic development in neurodegeneration
Gokul Ramaswami, Yeliz Yuva-Aydemir, … David A. Bumcrot·Scientific ReportsPeer-reviewed·Jan 25, 2024
- A Trisomy 21-linked Hematopoietic Gene Variant in Microglia Confers Resilience in Human iPSC Models of Alzheimers Disease
Mengmeng Jin, Ziyuan Ma, … Peng Jiang·bioRxiv·Mar 12, 2024
- A CRISPRi/a platform in iPSC-derived microglia uncovers regulators of disease states
Nina M. Dräger, Sydney M. Sattler, … Martin Kampmann·bioRxiv·Jun 16, 2021
- Inhibition of IL34 unveils tissue-selectivity and is sufficient to reduce microglial proliferation in chronic neurodegeneration
Juliane Obst, Emilie Simon, … Diego Gómez‐Nicola·Frontiers in ImmunologyPeer-reviewed·Oct 8, 2020